X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31809) 31809
Book Chapter (124) 124
Newsletter (91) 91
Conference Proceeding (44) 44
Dissertation (42) 42
Publication (35) 35
Magazine Article (23) 23
Government Document (10) 10
Book / eBook (8) 8
Journal / eJournal (8) 8
Newspaper Article (6) 6
Web Resource (6) 6
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23382) 23382
female (17082) 17082
oncology (15270) 15270
neoadjuvant therapy (14764) 14764
neoadjuvant chemotherapy (13219) 13219
middle aged (13046) 13046
aged (11114) 11114
cancer (11041) 11041
chemotherapy (10644) 10644
surgery (10161) 10161
male (10048) 10048
adult (9891) 9891
treatment outcome (7879) 7879
antineoplastic combined chemotherapy protocols - therapeutic use (7306) 7306
neoplasm staging (6811) 6811
prognosis (6537) 6537
chemotherapy, adjuvant (6310) 6310
breast cancer (6078) 6078
survival (5866) 5866
retrospective studies (5019) 5019
care and treatment (4599) 4599
carcinoma (4181) 4181
radiotherapy (4160) 4160
breast neoplasms - drug therapy (4087) 4087
combined modality therapy (3973) 3973
medicine & public health (3815) 3815
aged, 80 and over (3796) 3796
therapy (3693) 3693
breast neoplasms - pathology (3591) 3591
disease-free survival (3511) 3511
adjuvant treatment (3354) 3354
survival rate (3237) 3237
tumors (3011) 3011
analysis (2940) 2940
neoadjuvant therapy - methods (2855) 2855
chemoradiotherapy (2800) 2800
metastasis (2769) 2769
follow-up studies (2735) 2735
research (2711) 2711
antineoplastic agents - therapeutic use (2679) 2679
preoperative chemotherapy (2530) 2530
health aspects (2489) 2489
radiology, nuclear medicine & medical imaging (2436) 2436
survival analysis (2362) 2362
adjuvant chemotherapy (2307) 2307
cisplatin (2275) 2275
cisplatin - administration & dosage (2075) 2075
patients (2061) 2061
radiation-therapy (2022) 2022
trial (2010) 2010
colorectal cancer (1985) 1985
hematology, oncology and palliative medicine (1955) 1955
neoadjuvant (1929) 1929
radiotherapy, adjuvant (1920) 1920
fluorouracil - administration & dosage (1891) 1891
adenocarcinoma (1885) 1885
risk factors (1872) 1872
prospective studies (1865) 1865
cancer therapies (1839) 1839
gastroenterology & hepatology (1785) 1785
lymphatic metastasis (1780) 1780
randomized-trial (1712) 1712
esophageal cancer (1709) 1709
rectal cancer (1668) 1668
abridged index medicus (1666) 1666
rectal neoplasms - pathology (1658) 1658
obstetrics & gynecology (1654) 1654
biopsy (1647) 1647
chemoradiation (1623) 1623
young adult (1603) 1603
adenocarcinoma - pathology (1595) 1595
breast neoplasms - surgery (1591) 1591
time factors (1559) 1559
kaplan-meier estimate (1531) 1531
antineoplastic combined chemotherapy protocols - adverse effects (1521) 1521
magnetic resonance imaging (1508) 1508
patient outcomes (1508) 1508
rectal neoplasms - therapy (1482) 1482
adenocarcinoma - therapy (1444) 1444
surgical oncology (1413) 1413
cancer patients (1410) 1410
pathological complete response (1408) 1408
adolescent (1385) 1385
medical prognosis (1354) 1354
resection (1334) 1334
diagnosis (1317) 1317
squamous-cell carcinoma (1314) 1314
radiation therapy (1292) 1292
recurrence (1291) 1291
oncology, experimental (1281) 1281
phase-ii (1281) 1281
expression (1261) 1261
antineoplastic combined chemotherapy protocols - administration & dosage (1244) 1244
radiation (1236) 1236
women (1229) 1229
docetaxel (1228) 1228
pathology (1217) 1217
paclitaxel (1199) 1199
multivariate analysis (1189) 1189
predictive value of tests (1182) 1182
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29677) 29677
German (817) 817
Japanese (800) 800
French (690) 690
Chinese (319) 319
Spanish (196) 196
Russian (186) 186
Portuguese (81) 81
Italian (72) 72
Korean (66) 66
Hungarian (63) 63
Polish (38) 38
Czech (37) 37
Turkish (19) 19
Bulgarian (13) 13
Dutch (13) 13
Norwegian (9) 9
Romanian (8) 8
Danish (7) 7
Slovak (6) 6
Icelandic (5) 5
Persian (5) 5
Hebrew (4) 4
Finnish (3) 3
Ukrainian (2) 2
Arabic (1) 1
Belarusian (1) 1
Croatian (1) 1
Latvian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
.... We aimed to show the superiority of the neoadjuvant administration of histotype-tailored regimen to standard chemotherapy... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2010, Volume 119, Issue 2, pp. 212 - 216
Journal Article
by Cats, Annemieke and Jansen, Edwin P M and van Grieken, Nicole C T and Sikorska, Karolina and Lind, Pehr and Nordsmark, Marianne and Meershoek-Klein Kranenbarg, Elma and Boot, Henk and Trip, Anouk K and Swellengrebel, H A Maurits and van Laarhoven, Hanneke W M and Putter, Hein and van Sandick, Johanna W and van Berge Henegouwen, Mark I and Hartgrink, Henk H and van Tinteren, Harm and van de Velde, Cornelis J H and Verheij, Marcel and Van Coevorden, Frits and Vanhoutvin, Steven and Hulshof, Maarten CCM and Loosveld, Olaf JL and Ten Tije, A (Bert) Jan and Erdkamp, Frans LG and Warmerdam, Fabienne ARM and Van der Peet, Donald L and Verheul, Henk MW and Boerma, Djamila and Los, Maartje and Slot, Annerie and Houtsma, Danny and Portielje, Johanna EA and Blaisse, Reinoud JB and Spillenaar Bilgen, Ernst Jan and Polée, Marco B and Geenen, Maud M and Braak, Jeffrey PBM and Neelis, Karen J and Slingerland, Marije and Jansen, Rob LH and Buijsen, Jeroen and Beeker, Aart and Eijsbouts, Quirijn AJ and Van Riel, Johanna MGH and Rozema, Tom and Van Spronsen, Dick Johan and Meerum Terwogt, Jetske M and Tanis, Bea C and Van der Torren-Conze, Adelheid ME and Van Hilligersberg, Richard and Koopman, Miriam and Den Boer, Marien O and Creemers, Geert-Jan and Van der Sangen, Maurice and Rentinck, Marjolein EM and Van den Berg, H Pieter and Jonkers, Ge JPM and Grootenboers, Diane and Vulink, Annelie JE and Hovenga, Sjoerd and Van der Mijle, Huub CJ and Baars, Arnold and Haringhuizen, Annebeth W and Appels, Marije IE and Rietbroek, Ron C and Hendriksen, Ellen M and Legdeur, Marie-Cecile JC and Ten Bokkel Huinink, Daan and Van Dobbenburgh, O Aart and Smit, Jitty M and Van Bochove, Aart and Veldhuis, Gerrit-Jan and Muller, Erik W and Bonenkamp, J (Han) J and Braam, Pètra M and De Boer, Jaap and Van Halteren, Henk K and Valster, Fransje AA and Imholz, Alex LT and Van Dijk, Marjan A and Van der Gaast, Ate and Otten, J (Hans)-Martin MB and Ceha, Heleen M and Glimelius, Bengt and Lagerbäck, Cecillia and Perman, Mats and Johnsson, Anders and Borg, David and Nielsen, Niels H and Piwowar, Andrzej and Elmlund, Mattias and Hörberg, Helene and Edlund, Per and Johansson, Bengt and Flygare, Petra and Jespersen, Marie Louise and CRITICS investigators and CRITICS Investigators
The lancet oncology, ISSN 1470-2045, 2018, Volume 19, Issue 5, pp. 616 - 628
Both perioperative chemotherapy and postoperative chemoradiotherapy improve survival in patients with resectable gastric cancer from Europe and North America... 
CAPECITABINE | PERIOPERATIVE CHEMOTHERAPY | DOSE-ESCALATION | NODAL DISSECTION | CISPLATIN | ONCOLOGY | I-II | ADENOCARCINOMA | POSTOPERATIVE CHEMORADIOTHERAPY | FLUOROURACIL | III TRIAL | Neoadjuvant therapy | Chemotherapy | Stomach cancer | Analysis | Cancer
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 3, pp. 230 - 240
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 345 - 356
Journal Article
Journal Article
European urology, ISSN 0302-2838, 2017, Volume 72, Issue 4, pp. 544 - 554
Journal Article
European urology, ISSN 0302-2838, 2016, Volume 69, Issue 5, pp. 855 - 862
...) and cystectomy specimens would predict subtypes that could benefit from chemotherapy. Objective To explore clinical outcomes for patients treated with dose-dense (DD... 
Urology | Basal | Urothelial cancer | Dose-dense methotrexate cisplatin | Gene expression profiling | Luminal | Neoadjuvant | Subtype | Bevacizumab | p53 | METASTASIS | SUBTYPES | TUMORS | UROLOGY & NEPHROLOGY | CYSTECTOMY | CARCINOMA | INVASIVE BLADDER-CANCER | Urinary Bladder Neoplasms - classification | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Transcriptome | Bone Neoplasms - secondary | Male | Gene Expression Profiling | Vinblastine - administration & dosage | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Carcinoma, Transitional Cell - genetics | Doxorubicin - administration & dosage | Bevacizumab - administration & dosage | Proportional Hazards Models | Survival Rate | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Carcinoma, Transitional Cell - classification | Cystectomy | Carcinoma, Transitional Cell - drug therapy | Methotrexate - administration & dosage | Aged | Neoplasm Staging | Antimitotic agents | Anthracyclines | Patient outcomes | Adjuvant treatment | Product development | Genetic aspects | Tumor proteins | Antineoplastic agents | Gene expression | Cancer | Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin
Journal Article
Journal Article
European urology, ISSN 0302-2838, 2013, Volume 63, Issue 1, pp. 58 - 66
Journal Article